CClinicalTrials.gg
Status unknownNCT04403490Updated Jun 15, 2022

Effect of HABIT-ILE on the Body Function and Structures of Children With Cerebral Palsy

An interventional study of HABIT-ILE and Conventional intervention in Cerebral Palsy, sponsored by Université Catholique de Louvain. Status unknown at 1 site in Belgium. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2022-06-15.

Sponsored by Université Catholique de Louvain · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
5 Years to 18 Years
Sex
All
01

Study summary

There is strong evidence that recent intensive interventions based on motor skill learning principles are efficient on functional and neuroplastic changes of children with cerebral palsy (CP).

Besides, impaired selective voluntary motor control (SVMC) is one of four interrelated neuromuscular deficits in children with CP and is listed in the ICF-CY (International Classification of Functioning, Disability and Health for Children and Youth) under body functions. Additionally, impaired SVMC has been shown to negatively affect the motor and functional abilities of children with CP. However, there have been little scientific investigations on the trainability of SVMC according to therapeutic interventions.

Therefore, the study aims to evaluate the effect of Hand and Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) on the body function and structures of children with bilateral and unilateral cerebral palsy, including SVMC and brain structure.

02

Conditions studied

  • Cerebral Palsy

Keywords

  • motor skill learning
  • body function
  • body structure
  • selective voluntary motor control
  • brain structure
  • neuroplasticity
  • intensive therapy
  • cerebral palsy
03

In context

Paralysis

750 studies on the registry are indexed under Paralysis; 133 are open to participants now.

This study's planned enrollment of 60 is above the median of 30 across 537 interventional studies indexed under Paralysis.

Browse Paralysis studies →

Lead sponsor

Université Catholique de Louvain is the lead sponsor of 144 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed bilateral and unilateral cerebral palsy,
  • MACS levels from I to IV,
  • GMFCS levels from I to IV,
  • Ability to follow instructions and complete testing.

Exclusion criteria

Exclusion Criteria:

  • Orthopedic surgery, botulinum toxin injections or another unusual intervention less than 6 months before or within the study period.
  • Unstable seizure
  • Severe visual or cognitive impairments likely to interfere with intervention or testing session completion
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    HABIT-ILE

    Hand and arm bimanual intensive therapy including lower extremities

    Behavioral: HABIT-ILE

  • Active comparator
    Conventional intervention

    Conventional physical and occupational therapy

    Behavioral: Conventional intervention

Interventions

  • BehavioralHABIT-ILE

    2 weeks HABIT-ILE

  • BehavioralConventional intervention

    2 weeks usual intervention (waitlist group)

06

What researchers measure

Primary outcomes

  1. Changes in Diffusion Tensor Imaging (DTI)

    This sequence allows to measure changes in the fractional anisotropy (FA) on the white matter tracts. FA is a scalar value (no unit) between zero and one that describes the degree of anisotropy of white matter water molecules.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  2. Changes in Test of Arm Selective Control (TASC)

    The TASC is an upper limb selective motor control evaluation tool including eight motions in each arm and up to three attempts are allowed for each motion. This assessment tool was developed in 2010 and Sukal-Moulton et al. have proved its validity and reliability for children with CP in 2017. After completion of the best attempt, points ranging from 0 (absent), 1 (impaired) to 2 (normal) are recorded for each joint depending on the movement properties and descriptors of the test.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  3. Changes in Selective Control Assessment of the Lower Extremity (SCALE):

    The SCALE was designed to evaluate lower limb selective motor control of children with cerebral palsy. The SCALE includes testing of five reciprocal lower extremity movements. SVMC is graded at each joint as 'Normal' (2 points), 'Impaired' (1 point), or 'Unable' (0 points).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  4. Changes in Strength

    The strength will be measured for main muscle groups using a Microfet.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  5. Changes in Stiffness

    The stiffness will be measured using a device developed and already validated at UCLouvain.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

Secondary outcomes

  1. Changes in Assisting Hand Assessment (AHA or BoHA)

    The AHA is a videotaped tool measuring how effectively children with unilateral CP use the affected hand in bimanual activities. The BoHA is a videotaped tool measuring how effectively children with bilateral CP use both hands in bimanual activities.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  2. Changes in ABILHAND-Kids Questionnaire

    The ABILHAND-Kids Questionnaire has been developed to assess a child's unimanual and bimanual upper limb activities. It ranges from - 6 to +6 logits (higher score means better performance).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  3. Changes in ACTIVLIM-CP Questionnaire

    The ACTIVLIM-CP Questionnaire measures a patient's ability to perform daily activities requiring the use of the upper and/or the lower limbs through 42 items specific to patients with cerebral palsy. It ranges from - 5 to +5 logits (higher score means better performance).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  4. Changes in Gross Motor Function Measurement (GMFM 66)

    The GMFM has been developed to measure the change in gross motor function over time in children with cerebral palsy.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  5. Changes in 6 Minutes Walking Test (6MWT)

    The 6 Minutes Walking Test measures the distance that the patient walk as much as possible within a period of 6-minutes in a 30 meters long corridor.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  6. Changes in Box and Blocks test

    The BBT is a test of gross manual dexterity. Each hand is tested individually and the BBT is scored through the number of blocks carried over the partition from one part to another part of a box during the one-minute trial period.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  7. Changes in Jebsen-Taylor Test

    The Jebsen-Taylor Test assesses uni-manual hand function, through 7 subtests simulating daily life activities. The test assesses speed, not quality of performance and time to complete each activity is reported using a stopwatch.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  8. Changes in Modified Cooper test

    The Modified Cooper test is a modified version of The Manual Form Perception Test, which evaluates stereognosis through 16 objects. Both hands are tested separately and time to recognise the objects is reported using a stopwatch.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  9. Changes in ABILOCO-Kids Questionnaire

    The ABILOCO-Kids Questionnaire measures a patient's ability to perform daily activities requiring the use of the lower limbs through 10 items specific to patients with cerebral palsy. It ranges from - 4 to +4 logits (higher score means better performance).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  10. Changes in Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT)

    The PEDI-CAT is the new version of the Pediatric Evaluation of Disability Inventory (PEDI). The PEDI-CAT is comprised of 276 functional activities acquired throughout infancy, childhood and young adulthood. Based on the nternational Classification of Functioning, Disability and Health for Children and Youth (ICF-CY) model, the PEDI-CAT contents provide information about the activities and participation component. It ranges from 0 to 100% (higher score means better performance).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  11. Changes in Canadian Occupational Performance Measure (COPM)

    The COPM measures the patient's self-perception of occupational performance and satisfaction of it in daily activities over time. It ranges from 1 to 10, a higher score means a better performance.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  12. Changes in Double Inversion Recovery (DIR)

    This sequence allows to identify an inflamatory lesion.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  13. Changes in Functional resting state (RS)

    This sequence allows to evaluate the regional interactions that occur in a resting or task-negative state.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  14. Changes in T1-weighted and T2-weighted structural imaging

    The difference between these sequences allows to evaluated changes in the cortical myelin.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  15. Changes in Executive Functions

    Cognitive functions of the children will be assessed by Stroop task and Flanker task.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  16. Changes in spatial parameters of the gait (Kinematics assessments)

    Through a 3D motion system, we measure the stride length (meters), step length (meters) and step width (meters).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  17. Changes in temporal parameters of the gait (Cycle time)

    Through a 3D motion system, we measure the cycle of gait time (seconds).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  18. Changes in temporal parameters of the gait (Stance time)

    Through a 3D motion system, we measure the stance time (percentage of the total gait cycle).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  19. Changes in temporal parameters of the gait (Swing time)

    Through a 3D motion system, we measure the swing time (percentage of the total gait cycle).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  20. Changes in temporal parameters of the gait (Stride)

    Through a 3D motion system, we measure the gait cadence (stride per minute).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  21. Changes in temporal parameters of the gait (Velocity)

    Through a 3D motion system, we measure the gait velocity (meter/second).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  22. Changes in temporal parameters of the gait (Acceleration)

    Through a 3D motion system, we measure the gait acceleration (meters/second\^2)

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  23. Changes in spatial parameters of the upper extremity (Straightness)

    Through a 3D motion system, we measure the straightness (percentage of upper extremity trajectory during a reaching task).

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  24. Changes in spatial parameters of the upper extremity (Smoothness)

    Through a 3D motion system, we measure the smoothness (variability of the movement during a reaching task)

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

  25. Changes in temporal parameters of the upper extremity (Kinematics assessments)

    Through a 3D motion system, we measure the time from onset to end of the task (seconds). the task consists in a bimanual reaching task.

    Time frame: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04403490
Lead sponsor
Université Catholique de Louvain
Responsible party
Yannick Bleyenheuft (Professor, Université Catholique de Louvain) — Principal investigator
First posted
May 27, 2020
Start date
May 26, 2020
Primary completion
Nov 20, 2022 (estimated)
Completion
Dec 20, 2022 (estimated)
Last update
Jun 15, 2022

Study contacts

Yannick Bleyenheuft, Professor
Contact
yannick.bleyenheuft@uclouvain.be
+32 2 764 93 49
Seyma Kilcioglu, PhD Student
Contact
seyma.kilcioglu@student.uclouvain.be
Yannick Bleyenheuft
principal investigator · Institute of Neuroscience, UCLouvain

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion